Neos Therapeutics, Inc. SEC Filings

Filed On	Filing
30 Mar 2021	FORM 15-12B
25 Mar 2021	EFFECT
25 Mar 2021	EFFECT
25 Mar 2021	EFFECT
25 Mar 2021	EFFECT
22 Mar 2021	CURRENT REPORT
22 Mar 2021	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
19 Mar 2021	Form 4: Limongelli John M, SVP & General Counsel Returned 83,015 shares to the issuer · Disposed of 265,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Robinson James A. Jr., Director Returned 23,453 shares to the issuer · Disposed of 59,407 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: McLaughlin Gerald W., Director Returned 270,171 shares to the issuer · Disposed of 1,553,135 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Hecht Beth, Director Returned 23,453 shares to the issuer · Disposed of 115,262 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Schmid John P., Director Returned 23,453 shares to the issuer · Disposed of 115,262 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Fong Bryant, Director Returned 24,953 shares to the issuer · Disposed of 115,262 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Szyper Linda M, Director Returned 23,453 shares to the issuer · Disposed of 82,163 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Robitaille Gregory J, Director Returned 79,130 shares to the issuer · Disposed of 125,678 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Heller Alan L, Director Returned 446,819 shares to the issuer · Disposed of 115,262 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	Form 4: Eisenstadt Richard I, Chief Financial Officer Returned 126,245 shares to the issuer · Disposed of 655,423 Stock Option (Right to Buy) (Disposition to Issuer)
19 Mar 2021	S-8 POS
19 Mar 2021	S-8 POS
19 Mar 2021	S-8 POS

Comments